Patents Assigned to GANNEX PHARMA CO., LTD.
  • Pharmaceutical compositions, method of making and method of using thereof
    Patent number: 11752161
    Abstract: Pharmaceutical compositions suitable for long-term storage at room temperature are described. The pharmaceutical composition comprises the compound of formula (1) and can be used for the treatment of steatohepatitis. Also described are methods for preparing the pharmaceutical composition and methods of treatment using the pharmaceutical compositions.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: September 12, 2023
    Assignee: GANNEX PHARMA CO., LTD.
    Inventors: Jinzi Jason Wu, Xuyu Chai
  • Preparation method of a cyclic phosphonate compound
    Patent number: 11725019
    Abstract: A method for preparing the cyclic phosphonate compound of Formula I is described. The method significantly improves the stereoselectivity of the compound with the required configuration.
    Type: Grant
    Filed: March 3, 2022
    Date of Patent: August 15, 2023
    Assignee: GANNEX PHARMA CO LTD.
    Inventors: Jinzi J. Wu, Bailing Yang, Bin Liang
  • Pharmaceutical compositions comprising a thyroid hormone beta agonist, method of use and method making thereof
    Patent number: 11583502
    Abstract: A pharmaceutical formulation contains the following components in part by weight: (a) 1 part of the compound represented by Formula (I), (b) 16 to 600 parts of a meltable and dispersible carrier comprising poloxamer and polyethylene glycol in a poloxamer-to-polyethylene glycol weight ratio of 1-0.5 to 1:27, and (c) 0.2 to 100 parts of a non-volatile weak acid. The pharmaceutical formulation helps to improve the in vitro dissolution of the compound of Formula (I).
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: February 21, 2023
    Assignee: GANNEX PHARMA CO., LTD.
    Inventors: Jinzi Jason Wu, Xuyu Chai
  • Preparation method of a cyclic phosphonate compound
    Patent number: 11292805
    Abstract: A method for preparing the cyclic phosphonate compound of Formula I is described. The method significantly improves the stereoselectivity of the compound with the required configuration.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: April 5, 2022
    Assignee: GANNEX PHARMA CO., LTD.
    Inventors: Jinzi Jason Wu, Bailing Yang, Bin Liang